These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18952470)

  • 21. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
    Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
    Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
    Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
    Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
    Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).
    Roderfeld M; Hemmann S; Roeb E
    Z Gastroenterol; 2007 Jan; 45(1):25-33. PubMed ID: 17236118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of matrix metalloproteinases by ultraviolet radiation in the canine cornea.
    Chandler HL; Kusewitt DF; Colitz CM
    Vet Ophthalmol; 2008; 11(3):135-44. PubMed ID: 18435653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide.
    Zhang X; Wang HM; Lin HY; Liu GY; Li QL; Zhu C
    Placenta; 2004 Apr; 25(4):243-52. PubMed ID: 15028415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
    Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
    Massi D; Franchi A; Ketabchi S; Paglierani M; Pimpinelli N; Santucci M
    Hum Pathol; 2003 Jan; 34(1):80-8. PubMed ID: 12605370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer.
    Thomas P; Khokha R; Shepherd FA; Feld R; Tsao MS
    J Pathol; 2000 Feb; 190(2):150-6. PubMed ID: 10657012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis.
    Morris-Wiman J; Du Y; Brinkley L
    J Craniofac Genet Dev Biol; 1999; 19(4):201-12. PubMed ID: 10731089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
    Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
    J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.